This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maelandsmo, G. M. Articles by Florenes, V. A. Search for Related Content PubMed PubMed Citation Articles by Maelandsmo, G. M. Articles by Florenes, V. A.

American Journal of Pathology, Vol 149, 1813-1822, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions

GM Maelandsmo, R Holm, O Fodstad, RS Kerbel and VA Florenes
Department of Tumor Biology, Norwegian Radium Hospital, Oslo, Norway.

Immunohistochemical analysis of the expression of the cyclin kinase inhibitor p21WAF1/CIP1 in a panel of primary and metastatic human melanocytic tumors was performed. It was found that, independent of the p53 status, approximately 30% of the primary melanomas and 40% of the metastases completely lacked expression of this cell cycle inhibitor. Some tumors were also analyzed by Northern blotting, and in most of the cases a consistant correlation between mRNA and protein expression was observed. In four benign nevi studied, WAF1/CIP1 mRNA was expressed whereas the protein was not detected, suggesting a post-transcriptional regulation of the inhibitor in these cases. In superficial spreading melanomas, a significant correlation between protein expression and tumor thickness was found, with thin lesions showing low protein levels. Interestingly, by comparing primary and metastatic specimens obtained from the same patient, a reduction in p21WAF1/CIP1 antibody staining was observed in the latter, probably reflecting a more aggressive phenotype of the metastases. In conclusion, our results demonstrate the complexity in the relationship between p21WAF1/CIP1 expression and tumor phenotype and furthermore suggest that aberrant expression of the cyclin-dependent kinase inhibitor may be of importance in the development and progression of sporadic malignant melanoma.

This article has been cited by other articles:

				K. Jorgensen, R. Holm, G. M. Maelandsmo, and V. A. Florenes Expression of Activated Extracellular Signal-Regulated Kinases 1/2 in Malignant Melanomas: Relationship with Clinical Outcome Clin. Cancer Res., November 1, 2003; 9(14): 5325 - 5331. [Abstract] [Full Text] [PDF]

				G. M. Maelandsmo, R. Holm, J. M. Nesland, O. Fodstad, and V. A. Florenes Reduced {beta}-Catenin Expression in the Cytoplasm of Advanced-Stage Superficial Spreading Malignant Melanoma Clin. Cancer Res., August 1, 2003; 9(9): 3383 - 3388. [Abstract] [Full Text] [PDF]

				F. Mouriaux, C.-A. Maurage, P. Labalette, B. Sablonnière, F. Malecaze, and J.-M. Darbon Cyclin-Dependent Kinase Inhibitory Protein Expression in Human Choroidal Melanoma Tumors Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 2837 - 2843. [Abstract] [Full Text]

				B. Chen, L. He, V. H. Savell, J. J. Jenkins, and D. M. Parham Inhibition of the Interferon-{{gamma}}/Signal Transducers and Activators of Transcription (STAT) Pathway by Hypermethylation at a STAT-binding Site in the p21WAF1 Promoter Region Cancer Res., June 1, 2000; 60(12): 3290 - 3298. [Abstract] [Full Text]

				M. Baekelandt, R. Holm, C. G. Trope, J. M. Nesland, and G. B. Kristensen Lack of Independent Prognostic Significance of p21 and p27 Expression in Advanced Ovarian Cancer: An Immunohistochemical Study Clin. Cancer Res., October 1, 1999; 5(10): 2848 - 2853. [Abstract] [Full Text] [PDF]

				V. A. Florenes, G. M. Mælandsmo, R. S. Kerbel, J. M. Slingerland, J. M. Nesland, and R. Holm Protein Expression of the Cell-Cycle Inhibitor p27Kip1 in Malignant Melanoma : Inverse Correlation with Disease-Free Survival Am. J. Pathol., July 1, 1998; 153(1): 305 - 312. [Abstract] [Full Text] [PDF]

				Z. Kaleem, A. C. Lind, P. A. Humphrey, P. E. Swanson, R. H. Sueper, J. H. Ritter, and M. R. Wick Immunohistologic Evaluation of Putatively Mutant p53 Protein in Cutaneous Melanocytic Neoplasms: A Study of 256 Cases International Journal of Surgical Pathology, April 1, 1998; 6(2): 73 - 79. [Abstract] [PDF]

				H. H. Cha, E. J. Cram, E. C. Wang, A. J. Huang, H. G. Kasler, and G. L. Firestone Glucocorticoids Stimulate p21 Gene Expression by Targeting Multiple Transcriptional Elements within a Steroid Responsive Region of the p21waf1/cip1 Promoter in Rat Hepatoma Cells J. Biol. Chem., January 23, 1998; 273(4): 1998 - 2007. [Abstract] [Full Text] [PDF]